Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Aligo Venture Capital is a venture capital fund established in Poland, dedicated to collaborating with entrepreneurs who tackle global challenges. Founded to support projects that aim to mitigate the negative environmental impacts of the economy while enhancing human health, Aligo has positioned itself as a key player in the early-stage investment landscape.
The firm currently manages a portfolio that reflects its commitment to healthtech and cleantech sectors. Aligo Venture Capital typically engages as a sole investor or co-finances investment rounds, focusing on pre-seed and seed stage companies. The fund's investment strategy is characterized by its willingness to be the first investor in pre-revenue startups, providing essential early-stage capital.
As of now, Aligo Venture Capital has a team of five professionals, including partners and investment managers, who bring diverse expertise to the firm. Their active engagement in the market is evidenced by their recent activities, including notable exits from their portfolio.
Aligo Venture Capital specializes in early-stage investments, primarily targeting companies in the healthtech and cleantech sectors. The firm typically invests between €200,000 and €500,000, making it an attractive option for startups seeking initial funding. Their investment strategy emphasizes supporting innovations that leverage technology to improve health outcomes and promote environmental sustainability.
The firm often acts as a sole investor or co-finances rounds, allowing them to maintain a flexible approach to funding. Aligo Venture Capital is particularly interested in projects that address pressing health and environmental challenges, seeking to partner with entrepreneurs who share their vision for a healthier and more sustainable future.
In their own words, Aligo Venture Capital aims to back companies that are not only financially viable but also contribute positively to society and the environment. This dual focus on profitability and impact sets them apart in the venture capital landscape.
Aligo Venture Capital's portfolio includes a diverse range of companies that reflect its focus on health and environmental innovations. Notable portfolio companies include:
This portfolio illustrates Aligo's commitment to supporting innovative solutions that address significant health and environmental issues.
Agnieszka Stochmal - CFO: Agnieszka brings extensive financial expertise to Aligo, having previously worked in various financial roles within the venture capital sector.
Łukasz Mańkowski - Managing Partner: Łukasz has a strong background in venture capital and has led numerous successful investments in healthtech and cleantech.
Żaneta Kurszewska - Investment Manager: Żaneta specializes in identifying promising startups and has a keen eye for innovative solutions in the health sector.
Tomasz Chwiałkowski - Partner: Tomasz has a wealth of experience in operational management and strategic planning, contributing to the growth of portfolio companies.
Mikołaj Pióro - Investment Analyst: Mikołaj supports the investment team with market research and analysis, helping to identify trends and opportunities in the healthtech space.
To pitch Aligo Venture Capital, founders should submit their proposals through the project submission page on their website. It is essential to include a comprehensive deck that outlines the business model, market opportunity, and how the startup addresses health or environmental challenges.
Aligo Venture Capital prefers warm introductions but will consider direct submissions. Founders can expect a response within a few weeks, depending on the volume of submissions.
Recently, Aligo Venture Capital has been active in the investment ecosystem, with a notable blog post discussing the exit of Wellbeing Polska from their portfolio. This exit highlights the firm's ongoing engagement with its portfolio companies and the broader market.
As of now, there are no additional announcements or activities reported beyond this exit, but Aligo continues to monitor and support its existing investments.
What are Aligo Venture Capital's investment criteria?
Aligo Venture Capital focuses on early-stage companies in the healthtech and cleantech sectors. They typically invest in pre-seed and seed stage startups that leverage technology to address health and environmental challenges.
How can I pitch my startup to Aligo Venture Capital?
Interested founders can submit their projects through Aligo's project submission page available on their website. It is advisable to include a detailed business plan and information on how the startup addresses health or environmental issues.
What makes Aligo Venture Capital different from other investors?
Aligo Venture Capital distinguishes itself by focusing on the dual impact of health and environmental sustainability. Their commitment to being the first investor in pre-revenue startups allows them to support innovative ideas from the ground up.
What is the typical check size for investments?
Aligo Venture Capital typically invests between €200,000 and €500,000 in their portfolio companies, providing essential early-stage funding.
What geographic areas does Aligo Venture Capital focus on?
The firm primarily invests in companies based in Europe, particularly those that align with their focus on health and environmental challenges.
What kind of support can portfolio companies expect post-investment?
Aligo Venture Capital actively engages with its portfolio companies, providing not only financial support but also strategic guidance and resources to help them grow and succeed in their respective markets.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.